NCT Number: NCT02989545
The Use of an "Anal-Tape" in Patients With Fecal Incontinence
Fecal incontinence (FI), defined as the involuntary passage of stool for more than 3 months and is a devastating disease. The negative impact on quality of life has been consistently demonstrated. The prevalence of FI is probably underestimated in most studies. Currently conservative treatment is only modestly effective and surgical treatment is complex and expensive with less than optimal efficacy.
The investigators developed an "anal tape" using a commercially available elastic band with a special adhesive that is approved for use in the skin. A special design of the tape can be applied to the skin surrounding the anus providing support and additional pressure forces to the anal sphincter.
This is a 4 week, prospective, non blinded, cross-over study to explore the efficacy and safety of this device in patients with FI. The primary endpoint will be improvement in quality of life.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- >18 years old
- Fecal incontinence for more than 6 months
- Willing to participate
- Understand the study procedures
- Is able to apply and remove the "anal tape" without significant assistance of others.
- Have done sigmoidsocopy or colonoscopy and anal manometry within five year of screening visit
Exclusion criteria
- Advanced full thickness rectal prolapse.
- Injured, inflamed or any significant disease in the peri-anal skin.
- Allergy to any component of the device, either known or developed during testing in the screening visit.
- Moderate to severe proctitis of any etiology.
Treatment and study plan
Primary outcomes
-
Any Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)
Time frame: 2 weeks
The FIQoL is a validated, condition-specific tool that evaluates quality of life (QoL) in patients with fecal incontinence (FI) it consisting of 29 questions, subdivided into four domains: Lifestyle, Coping/Behavior, Depression/Self-perception, and Embarrassment. Item 1, general health, is graded from 1 "excellent" to 5 "poor" and is reversely scored. Items 2 to 28 are graded on a 4-point Likert-scale (1 = lower QoL). Item 29, FI specific depression, is graded from 1 "extremely so" to 6 "not at all." The average score for each domain is calculated separately and is calculated only if half or more of the items in the particular domain have been answered. Scales range from 1 to 5, with a 1 indicating a lower quality of life. Each domain or subscale is reported separately (Range 1 to 5), a total score including all four domains is not calculated.
Secondary outcomes
-
A 50% Reduction in the Number of Episodes of FI Per Week
Time frame: 4 weeks
Number of pateints with reduction of more than 50% in the absolute number of FI events during each week of the study
-
Mean Wexner Score
Time frame: 2 weeks
The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
-
Mean Redction in Wexner Scale Compared to Baseline
Time frame: 2 weeks
The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
-
General Satisfaction
Time frame: 2 weeks
General satisfaction with the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their satisfaction with the device between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.
-
Willingness of the Patient to Continue Using the Anal Tape After the Study.
Time frame: 4 weeks
Willingness of the patient to continue using the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their willingness to use the device in the future between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.
Sponsors and collaborators
Lead sponsor
Shaare Zedek Medical Center
Other
Registry information
Important dates
- Study start
- 2016
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Dec 12, 2016
- Registry last updated
- Apr 2, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Role of Fiber in the Prevention and Treatment of Fecal Incontinence
NCT04806386
Colonic Diseases, Colonic Diseases, Functional
Boston, Massachusetts, United States
View Trial DetailsEffect of Lumbo-sacral Magnetic Stimulation on Colonic Motility
NCT00213317
Colonic Diseases, Colonic Diseases, Functional
Rouen, France
View Trial DetailsEffect of Sacral Nerve Stimulation on Enteric Nervous System
NCT01786304
Digestive System Diseases, Fecal Incontinence
Rouen, Normandy, France
View Trial DetailsTreatment of Fecal Incontinence and Chronic Constipation With Low-volume Irrigation
NCT05773742
Constipation, Digestive System Diseases
Aarhus, Denmark
View Trial Details